117 related articles for article (PubMed ID: 21880230)
1. A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.
Frias JP; Bode BW; Bailey TS; Kipnes MS; Brunelle R; Edelman SV
J Diabetes Sci Technol; 2011 Jul; 5(4):887-93. PubMed ID: 21880230
[TBL] [Abstract][Full Text] [Related]
2. Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.
Edelman SV; Bode BW; Bailey TS; Kipnes MS; Brunelle R; Chen X; Frias JP
Diabetes Technol Ther; 2010 Aug; 12(8):627-33. PubMed ID: 20615104
[TBL] [Abstract][Full Text] [Related]
3. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA
JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991
[TBL] [Abstract][Full Text] [Related]
4. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus.
Rubin RR; Peyrot M; Chen X; Frias JP
Diabetes Technol Ther; 2010 Nov; 12(11):901-6. PubMed ID: 20879963
[TBL] [Abstract][Full Text] [Related]
6. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.
King AB; Clark D; Wolfe GS
Diabetes Technol Ther; 2012 Oct; 14(10):900-3. PubMed ID: 22845649
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
8. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y
Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571
[TBL] [Abstract][Full Text] [Related]
9. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
Ziegler R; Cavan DA; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
Diabetes Care; 2013 Nov; 36(11):3613-9. PubMed ID: 23900590
[TBL] [Abstract][Full Text] [Related]
10. Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis.
Sutton D; Higdon CD; Nikkel C; Hilsinger KA
Adv Ther; 2018 May; 35(5):631-643. PubMed ID: 29748915
[TBL] [Abstract][Full Text] [Related]
11. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
[TBL] [Abstract][Full Text] [Related]
13. Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study.
Huffman DM; McLean GW; Seagrove MA
Endocr Pract; 2009; 15(7):689-95. PubMed ID: 19546056
[TBL] [Abstract][Full Text] [Related]
14. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
[TBL] [Abstract][Full Text] [Related]
15. Clinical Experience with U-500 Regular Insulin by Multiple Daily Injections and Continuous Subcutaneous Insulin Infusion.
Meade LT; Tart RC; Nuzum D
Diabetes Technol Ther; 2017 Apr; 19(4):220-225. PubMed ID: 28249123
[TBL] [Abstract][Full Text] [Related]
16. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
17. EADSG Guidelines: Insulin Therapy in Diabetes.
Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of selected methods of the short-term intensive insulin therapy in patients with poorly controlled type 2 diabetes mellitus].
Ruxer J; Mozdzan M; Czupryniak L; Saryusz-Wolska M; Loba J
Pol Arch Med Wewn; 2004 Aug; 112(2):945-52. PubMed ID: 15675270
[TBL] [Abstract][Full Text] [Related]
19. Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes.
Aronson R; Mahoney E; Saliu D; Sze D; Morel D; Bergquist L; Hirsch L
Diabetes Technol Ther; 2020 May; 22(5):352-359. PubMed ID: 31692373
[No Abstract] [Full Text] [Related]
20. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.
Janka HU; Plewe G; Riddle MC; Kliebe-Frisch C; Schweitzer MA; Yki-Järvinen H
Diabetes Care; 2005 Feb; 28(2):254-9. PubMed ID: 15677775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
